Company Overview and News

 
BHP Trims Iron Ore Guidance—How Iron Ore Prices Could Respond

2018-04-19 marketrealist
On April 18, BHP Billiton (BHP) released its operational review of the nine months ended March 2018. Iron ore (PICK) volumes are key to BHP Billiton’s revenues and earnings, as iron ore is the largest commodity produced by the company.
Upvote Downvote

 
Why Commodity Stocks Surged on April 18—All You Need to Know

2018-04-19 marketrealist
April 18, 2018, belonged to commodity stocks (COMT), some of which saw their highest one-day gains in months. Among the iron ore and diversified companies, Glencore (GLNCY) surged 7.7%, and Anglo American (AAUKY) saw price gains of 6.2%. BHP Billiton (BHP), Rio Tinto (RIO), Vale SA (VALE), and Cleveland-Cliffs (CLF) rose 3.3%, 4.0%, 4.2%, and 4.4%, respectively.
Upvote Downvote

 
China’s Economic Stats Have a Credibility Problem - Bloomberg

2018-04-19 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Prosecutors, Samarco to ask more time for disaster's compensation plan

2018-04-18 reuters
RIO DE JANEIRO (Reuters) - Brazilian federal prosecutors and mining company Samarco are going to ask a local court for additional time to conclude a compensation plan for victims of a dam disaster in Brazil’s Minas Gerais state, the prosecutor’s office said on Wednesday.
Upvote Downvote

 
UPDATE 1-Brazil's Vale reports iron ore output slips in Q1

2018-04-16 reuters
RIO DE JANEIRO/BRASILIA, April 16 (Reuters) - Brazilian miner Vale SA said on Monday that total iron ore output slipped 4.9 percent year-on-year in the first quarter to 81.95 million tonnes, although the company maintained its 390 million tonne target for 2018.
Upvote Downvote

 
World's top iron shipper says China import boom to level off

2018-04-10 thestar.com.my
Rising output: A file picture showing machinery operating in a pit at Rio Tinto Group’s West Angelas iron ore mine in Pilbara, Australia. The country’s department of Industry, Innovation and Science is predicting rising global volumes this year. — Bloomberg
Upvote Downvote

 
Pension fund Previ not likely to sell its Vale shares in 2018 -source

2018-04-04 reuters
SAO PAULO (Reuters) - Brazilian pension fund Previ is not likely to sell its shares in Vale SA (VALE3.SA) in a public offering this year, a person with knowledge of the matter said on Wednesday, a week after the iron ore miner announced a more generous dividend policy.
Upvote Downvote

 
Could Iron Ore and Miners Fall More amid Trade War Fears?

2018-03-29 editors.aws.marketrealist
Iron ore prices have been tumbling lately due to increasing inventories as well as a waning steel appetite. They fell 7.5% for the week ended March 23, 2018, and 18.7% since March 1, 2018.
Upvote Downvote

 
Why Vale Keeps Executive Pay Secret - Bloomberg

2018-03-28 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Horizonte Minerals Plc: Final Results

2018-03-27 globenewswire
LONDON, March 27, 2018 (GLOBE NEWSWIRE) -- Horizonte Minerals Plc, (AIM:HZM) (TSX:HZM) (‘Horizonte’ or ‘the Company’) the nickel development company focused in Brazil, announces its final results for the year ended 31 December 2017. Highlights
Upvote Downvote

 
Argentina to tender shale train to develop Vaca Muerta drilling

2018-03-24 worldoil
BUENOS AIRES (Bloomberg) -- Argentina is readying a tender for a $500 million train line that could help unlock the potential of Vaca Muerta, one of the world’s biggest shale plays, Transport Minister Guillermo Dietrich said in an interview.
Upvote Downvote

 
ETFs to be Impacted by Trump's Tariff Exemptions

2018-03-23 zacks
The markets have had a rough first quarter. After inflation and rate hike fears spooked the markets in February, it saw a slight recovery as wage growth slowed. However, March has not been welcoming either, as President Donald Trump’s plans of imposing tariffs didn’t bode well for the markets (read: Watch These ETFs as Trade War Risks Rise).
Upvote Downvote

 
Argentina Eyes $500 Million Rail Project to Boost Shale Play

2018-03-23 rigzone
(Bloomberg) -- Argentina is readying a tender for a $500 million train line that could help unlock the potential of Vaca Muerta, one of the world’s biggest shale plays, Transport Minister Guillermo Dietrich said in an interview.
Upvote Downvote

 
This Commodity Investor Is Hoarding the World’s Cobalt Supply - Bloomberg

2018-03-16 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
Upvote Downvote

 
Cramer's lightning round: I can't find a reason to buy Kraft Heinz

2018-03-08 cnbc
Kraft Heinz Co.: "I don't know, man. It's at a 52-week low, it yields 3.7 [percent], yet I still can't find a compelling reason to buy it. I like growth."
Upvote Downvote

Related Articles

RDHL: Redhill Biopharma Ltd (OTC:REDIF) Analysis and Research Report

2018-04-18 - Asif

History and Development of the Company The company's legal and commercial name is RedHill Biopharma Ltd. The company's company was incorporated on August 3, 2009, and was registered as a private company limited by shares under the laws of the State of Israel. The company's principal executive offices are located at 21 Ha’arba’a Street, Tel Aviv, Israel. In February 2011, the company completed its initial public offering in Israel, pursuant to which the company issued 14,302,300 Ordinary Shares, and 7,151,150 tradable Series 1 Warrants to purchase 7,151,150 Ordinary Shares for aggregate gross proceeds of approximately $14 million. On December 27, 2012, the company completed the listing of its ADSs on the NASDAQ Capital Market. The company's Ordinary Shares are traded on the Tel-Aviv Stock Exchange under the symbol “RDHL,” and its ADSs are traded on the NASDAQ Capital Market under the same symbol "RDHL". The company's capital expenditures for the years ended December 31, 2...

SCYX: SCYNEXIS Analysis and Research Report

2018-04-16 - Asif

Overview SCYNEXIS, Inc. is a biotechnology company committed to positively impacting the lives of patients suffering from difficult-to-treat and often life-threatening infections by delivering innovative anti-infective therapies. SCYNEXIS is developing its lead product candidate, SCY-078, as the first representative of a novel oral and intravenous (IV) triterpenoid antifungal family in clinical development for the treatment of several serious fungal infections, including invasive candidiasis, invasive aspergillosis, refractory invasive fungal infections and vulvovaginal candidiasis (VVC). SCY-078 is a structurally distinct glucan synthase inhibitor that has been shown to be effective in vitro and in vivo against a broad range of human fungi pathogens such as Candida and Aspergillus species, including multidrug-resistant strains, as well as Pneumocystis species. Candida and Aspergillus species are the fungi responsible for approximately 85% of all invasive fungal infections in t...

ENRT: Enertopia Corp (CNSX:TOP) Analysis and Research Report

2018-04-16 - Asif

Business History Enertopia Corp. was formed on November 24, 2004 under the laws of the State of Nevada and commenced operations on November 24, 2004. From inception until April 2010, the company were primarily engaged in the acquisition and exploration of natural resource properties. Beginning in April 2010, the company began its entry into the renewable energy sector by purchasing an interest in a solar thermal design and installation company. In late summer 2013, the company began its entry into medicinal marijuana business. During its 2014 fiscal year end its activities in the clean energy sector were discontinued. During fiscal 2015 its activities in the Medicinal Marijuana sector were discontinued. During fiscal 2016 its activities in the Women’s personal healthcare sector were discontinued. The Company is actively pursuing business opportunities in the resource sector, whereby the company signed a definitive agreement for a Lithium Brine Project in May 2016. In May ...

FB: Facebook Analysis and Research Report

2018-04-15 - Asif

Overview The company's mission is to give people the power to build community and bring the world closer together. The company's top priority is to build useful and engaging products that enable people to connect and share with friends and family through mobile devices, personal computers, and other surfaces. The company also help people discover and learn about what is going on in the world around them, enable people to share their opinions, ideas, photos and videos, and other activities with audiences ranging from their closest friends to the public at large, and stay connected everywhere by accessing its products, including: Facebook enables people to connect, share, discover, and communicate with each other on mobile devices and personal computers. There are a number of different ways to engage with people on Facebook, the most important of which is News Feed which displays an algorithmically-ranked series of stories and advertisements individualized for each pers...

VSTM: Verastem Analysis and Research Report

2018-04-12 - Asif

Business Overview Verastem is a biopharmaceutical company focused on developing and commercializing drugs to improve the survival and quality of life of cancer patients. The company's most advanced product candidates, duvelisib and defactinib, utilize a multi-faceted approach to treat cancers originating either in the blood or major organ systems. Verastem is currently evaluating these compounds in both preclinical and clinical studies as potential therapies for certain cancers, including leukemia, lymphoma, lung cancer, ovarian cancer, mesothelioma, and pancreatic cancer. The company believe that these compounds may be beneficial as therapeutics either as single agents or when used in combination with immuno-oncology agents or other current and emerging standard of care treatments in aggressive cancers that are poorly served by currently available therapies. Duvelisib targets the Phosphoinositide 3-kinase (PI3K) signaling pathway. The PI3K signaling pathway plays a centr...